Metabolix (MBLX) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Metabolix Announces Fourth Quarter and Full Year 2014 Financial Results
March 19, 2015 4:05 PM EDTCAMBRIDGE, Mass., March 19, 2015 (GLOBE NEWSWIRE) -- Metabolix, Inc. (Nasdaq: MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and full year ended December 31, 2014.
"In 2014 we began implementing a plan to reshape Metabolix into a specialty biopolymers company," said Joe Shaulson, president and CEO of Metabolix. "We focused our strategy on commercializing our PHA biopolymers as performance additives in high value applications. We also restructured our U.S. organization, sold our German operations and raised $25 million in a private placement... More
